Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

A-H Premium Weekly (Jun 6th): Jiangsu Expressway, Sichuan Expressway, CICC

A-H Premium Weekly (Jun 13th): Tigermed, Bank Of Chongqing, Sinopec Oilfield Service

A-H Premium Weekly (Jun 20th): Petrochina, Shanghai Junshi Biosciences, China Oilfield Services

A-H Premium Weekly (May 23rd): CATL and Hengrui Listing Lowered Premium

A-H Premium Weekly (May 16th): Cosco Shipping Development, Qingdao Port International

A-H Premium Weekly (May 9th): Datang Intl Power Gen, Beigene, CSSC O&M Engineering

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

China Health care / Quantitative Analysis

Zhuzhou CRRC Times Electric Co., Ltd. (3898 HK)

<ul>
<li>We analyse the changes of A-H premium on 154 stocks over the last week. The average A-H premium was 79.2% as of May 30th.</li>
<li>The average A-H premium changed by -1.3ppt week-on-week, led by health care, information technology, utilities and offset by consumer staples, materials.</li>
<li>We highlight weekly changes in A-H premium for Tigermed, Fosun Pharma, Cosco Shipping, CSSC O&amp;M Engineering, Joinn Lab, Livzon Pharmaceutical.</li>
</ul>


We analyse the changes of A-H premium on 154 stocks over the last week. The average A-H premium was 79.2% as of May 30th.
The average A-H premium changed by -1.3ppt week-on-week, led by health care, information technology, utilities and offset by consumer staples, materials.
We highlight weekly changes in A-H premium for Tigermed, Fosun Pharma, Cosco Shipping, CSSC O&amp;M Engineering, Joinn Lab, Livzon Pharmaceutical.


China Communications Construction (1800 HK)

Hangzhou Tigermed Consulting (A) (300347 CH)

China Railway Signal & Communication (3969 HK)

Zhengzhou Coal Mining Machinery Group Co (601717 CH)

Cssc Offshore & Marine Engg Group (317 HK)

Dynagreen Environmental Prtctn Gp (1330 HK)

Zhengzhou Coal Mining Machinery Group Co (564 HK)

Shanghai Fosun Pharmaceutical (Group) (2196 HK)

Dongfang Electric Corporation (600875 CH)

Shanghai Fosun Pharmaceutical (Group) (600196 CH)

Shanghai Fudan Microelectronics H (1385 HK)

Contemporary Amperex Technology (CATL) (300750 CH)

Livzon Pharmaceutical Group In (000513 CH)

CSSC Offshore and Marine Engin (600685 CH)

China Railway Signal & Communi (688009 CH)

China Communications Construct (601800 CH)

Hainan Drinda Automotive Trim (002865 CH)

Shanghai Fudan Microelectronic (688385 CH)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (688505 CH)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical

Contemporary Amperex Technology (CATL) (3750 HK)

A-H Premium Weekly (May 30th): Tigermed, Fosun Pharma, Cosco Shipping, CSSC O&M Engineering